These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 22808306)

  • 1. Safety and Effectiveness of a New Blue Light Device for the Self-treatment of Mild-to-moderate Acne.
    Wheeland RG; Koreck A
    J Clin Aesthet Dermatol; 2012 May; 5(5):25-31. PubMed ID: 22808306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of self-treatment of mild-to-moderate facial acne with a blue light treatment system.
    Wheeland RG; Dhawan S
    J Drugs Dermatol; 2011 Jun; 10(6):596-602. PubMed ID: 21637900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined 400-600nm and 800-1200nm Intense Pulsed Phototherapy of Facial Acne Vulgaris.
    Knight JM
    J Drugs Dermatol; 2019 Nov; 18(11):1116-1122. PubMed ID: 31741354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brightening and Improvement of Facial Skin Quality in Healthy Female Subjects With Moderate Hyperpigmentation or Dark Spots and Moderate Facial Aging.
    Serra M; Bohnert K; Narda M; Granger C; Sadick N
    J Drugs Dermatol; 2018 Dec; 17(12):1310-1315. PubMed ID: 30586263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Seven-week, Open-label Trial Evaluating the Safety and Efficacy of a Photopneumatic Device for Mitigating Mild-to-Moderate Acne in Healthy Adolescents and Young Adults.
    Ablon G
    J Clin Aesthet Dermatol; 2024 Jun; 17(6):13-20. PubMed ID: 38912192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomised controlled multiple treatment comparison to provide a cost-effectiveness rationale for the selection of antimicrobial therapy in acne.
    Ozolins M; Eady EA; Avery A; Cunliffe WJ; O'Neill C; Simpson NB; Williams HC
    Health Technol Assess; 2005 Jan; 9(1):iii-212. PubMed ID: 15588555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized controlled study for the treatment of acne vulgaris using high-intensity 414 nm solid state diode arrays.
    Ash C; Harrison A; Drew S; Whittall R
    J Cosmet Laser Ther; 2015; 17(4):170-6. PubMed ID: 25594129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of two anti-acne/anti-aging treatments in subjects with photodamaged skin and mild to moderate acne vulgaris.
    Kircik LH; Dahl A; Yatskayer M; Raab S; Oresajo C
    J Drugs Dermatol; 2012 Jun; 11(6):737-40. PubMed ID: 22648221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Tolerability of a Novel Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate or Severe Acne Vulgaris in Adult Females.
    Harper JC; Baldwin H; Stein Gold L; Guenin E
    J Drugs Dermatol; 2019 Nov; 18(11):1147-1154. PubMed ID: 31741360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An open study to determine the efficacy of blue light in the treatment of mild to moderate acne.
    Morton CA; Scholefield RD; Whitehurst C; Birch J
    J Dermatolog Treat; 2005; 16(4):219-23. PubMed ID: 16249142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tretinoin gel microspheres 0.04% versus 0.1% in adolescents and adults with mild to moderate acne vulgaris: a 12-week, multicenter, randomized, double-blind, parallel-group, phase IV trial.
    Berger R; Rizer R; Barba A; Wilson D; Stewart D; Grossman R; Nighland M; Weiss J
    Clin Ther; 2007 Jun; 29(6):1086-97. PubMed ID: 17692723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Efficacy of Self-applied Blue Light Therapy for Mild-to-Moderate Facial Acne.
    Gold MH; Andriessen A; Biron J; Andriessen H
    J Clin Aesthet Dermatol; 2009 Mar; 2(3):44-50. PubMed ID: 20729943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and usability study to determine the safety and efficacy of the Silk'n Blue Device for the treatment of mild to moderate inflammatory acne vulgaris.
    Gold MH; Biron JA; Sensing W
    J Cosmet Laser Ther; 2014 Jun; 16(3):108-13. PubMed ID: 24143960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An extension of a multicenter, randomized, split-face clinical trial evaluating the efficacy and safety of chromophore gel-assisted blue light phototherapy for the treatment of acne.
    Nikolis A; Fauverghe S; Scapagnini G; Sotiriadis D; Kontochristopoulos G; Petridis A; Rigopoulos D; Dessinioti C; Kalokasidis K; Antoniou C
    Int J Dermatol; 2018 Jan; 57(1):94-103. PubMed ID: 29152718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicenter, randomized, split-face clinical trial evaluating the efficacy and safety of chromophore gel-assisted blue light phototherapy for the treatment of acne.
    Antoniou C; Dessinioti C; Sotiriadis D; Kalokasidis K; Kontochristopoulos G; Petridis A; Rigopoulos D; Vezina D; Nikolis A
    Int J Dermatol; 2016 Dec; 55(12):1321-1328. PubMed ID: 27575854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Phase 2b, Randomized, Double-Blind Vehicle Controlled, Dose Escalation Study Evaluating Clascoterone 0.1%, 0.5%, and 1% Topical Cream in Subjects With Facial Acne.
    Mazzetti A; Moro L; Gerloni M; Cartwright M
    J Drugs Dermatol; 2019 Jun; 18(6):570. PubMed ID: 31251550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Effectiveness and Safety of Up to 48 Weeks' Treatment with Topical Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel in the Prevention and Reduction of Atrophic Acne Scars in Moderate and Severe Facial Acne.
    Dréno B; Bissonnette R; Gagné-Henley A; Barankin B; Lynde C; Chavda R; Kerrouche N; Tan J
    Am J Clin Dermatol; 2019 Oct; 20(5):725-732. PubMed ID: 31209851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BPX-01 Minocycline Topical Gel Shows Promise for the Treatment of Moderate-to-severe Inflammatory Acne Vulgaris.
    Alexis A; Del Rosso JQ; Desai SR; Downie JB; Draelos ZD; Feser C; Forconi R; Fowler JF; Gold M; Kaufman-Janette J; Lain E; Lee M; Ling M; Shamban AT; Werschler WP; Daniels A
    J Clin Aesthet Dermatol; 2018 Nov; 11(11):25-35. PubMed ID: 30588271
    [No Abstract]   [Full Text] [Related]  

  • 19. Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate and Severe Acne Vulgaris in Females: Effect of Age on Efficacy and Tolerability.
    Stein Gold L; Pariser DM; Guenin E
    J Drugs Dermatol; 2019 Dec; 18(12):1218-1225. PubMed ID: 31860209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris: Impact of Gender and Race on Efficacy and Safety.
    Lain E; Day D; Harper J; Guenin E
    J Drugs Dermatol; 2019 Nov; 18(11):1128-1138. PubMed ID: 31741356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.